Molecular Characteristics and Prevalence of Rifampin Resistance in <i>Staphylococcus aureus</i> Isolates from Patients with Bacteremia in South Korea
Rifampin resistance (RIF-R) in <i>Staphylococcus aureus</i> (<i>S. aureus</i>) with <i>rpoB</i> mutations as one of its resistance mechanisms has raised concern about clinical treatment and infection prevention strategies. Data on the prevalence and molecular epid...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_bf9bccaa25ed49c8a5f11db37f95bc5a | ||
042 | |a dc | ||
100 | 1 | 0 | |a Yong Kyun Kim |e author |
700 | 1 | 0 | |a Yewon Eom |e author |
700 | 1 | 0 | |a Eunsil Kim |e author |
700 | 1 | 0 | |a Euijin Chang |e author |
700 | 1 | 0 | |a Seongman Bae |e author |
700 | 1 | 0 | |a Jiwon Jung |e author |
700 | 1 | 0 | |a Min Jae Kim |e author |
700 | 1 | 0 | |a Yong Pil Chong |e author |
700 | 1 | 0 | |a Sung-Han Kim |e author |
700 | 1 | 0 | |a Sang-Ho Choi |e author |
700 | 1 | 0 | |a Sang-Oh Lee |e author |
700 | 1 | 0 | |a Yang Soo Kim |e author |
245 | 0 | 0 | |a Molecular Characteristics and Prevalence of Rifampin Resistance in <i>Staphylococcus aureus</i> Isolates from Patients with Bacteremia in South Korea |
260 | |b MDPI AG, |c 2023-10-01T00:00:00Z. | ||
500 | |a 10.3390/antibiotics12101511 | ||
500 | |a 2079-6382 | ||
520 | |a Rifampin resistance (RIF-R) in <i>Staphylococcus aureus</i> (<i>S. aureus</i>) with <i>rpoB</i> mutations as one of its resistance mechanisms has raised concern about clinical treatment and infection prevention strategies. Data on the prevalence and molecular epidemiology of RIF-R <i>S. aureus</i> blood isolates in South Korea are scarce. We used broth microdilution to investigate RIF-R prevalence and analyzed the <i>rpoB</i> gene mutation in 1615 <i>S. aureus</i> blood isolates (772 methicillin-susceptible and 843 methicillin-resistant <i>S. aureus</i> (MRSA)) from patients with bacteremia, between 2008 and 2017. RIF-R prevalence and antimicrobial susceptibility were determined. Multilocus sequence typing was used to characterize the isolate's molecular epidemiology; Staphylococcus protein A (s<i>pa</i>)<i>,</i> staphylococcal cassette chromosome <i>mec</i> (SCC<i>mec</i>), and <i>rpoB</i> gene mutations were detected by PCR. Among 52 RIF-R MRSA isolates out of 57 RIF-R <i>S. aureus</i> blood isolates (57/1615, 0.4%; 5 methicillin-susceptible and 52 MRSA), ST5 (44/52, 84.6%), SCC<i>mec</i> IIb (40/52, 76.9%), and <i>spa</i> t2460 (27/52, 51.9%) were predominant. <i>rpoB</i> gene mutations with amino acid substitutions showed that A477D (17/48, 35.4%) frequently conferred high-level RIF resistance (MIC > 128 mg/L), followed by H481Y (4/48, 8.3%). RIF-R <i>S. aureus</i> blood isolates in South Korea have unique molecular characteristics and are closely associated with <i>rpoB</i> gene mutations. RIF-R surveillance through <i>S. aureus</i>-blood isolate epidemiology could enable effective therapeutic management. | ||
546 | |a EN | ||
690 | |a rifampin resistance | ||
690 | |a <i>Staphylococcus aureus</i> | ||
690 | |a bacteremia | ||
690 | |a molecular typing | ||
690 | |a <i>rpoB</i> gene | ||
690 | |a mutation | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Antibiotics, Vol 12, Iss 10, p 1511 (2023) | |
787 | 0 | |n https://www.mdpi.com/2079-6382/12/10/1511 | |
787 | 0 | |n https://doaj.org/toc/2079-6382 | |
856 | 4 | 1 | |u https://doaj.org/article/bf9bccaa25ed49c8a5f11db37f95bc5a |z Connect to this object online. |